0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Companion Animal Speciality Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25Y7068
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Companion Animal Speciality Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Companion Animal Speciality Drugs Market Research Report 2025

Code: QYRE-Auto-25Y7068
Report
September 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Companion Animal Speciality Drugs Market Size

The global market for Companion Animal Speciality Drugs was valued at US$ 13710 million in the year 2024 and is projected to reach a revised size of US$ 18640 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Companion Animal Speciality Drugs Market

Companion Animal Speciality Drugs Market

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 30%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Companion Animal Speciality Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Speciality Drugs.
The Companion Animal Speciality Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Companion Animal Speciality Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Animal Speciality Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Companion Animal Speciality Drugs Market Report

Report Metric Details
Report Name Companion Animal Speciality Drugs Market
Accounted market size in year US$ 13710 million
Forecasted market size in 2031 US$ 18640 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antibiotics
  • Anti-inflammatory Drugs
  • Parasiticides
  • Heartworm
  • Nutritional Products
  • Anti-Obesity Drugs
  • Skin Care Products
  • Vaccines
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim, Ceva Sante Animale
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Companion Animal Speciality Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Companion Animal Speciality Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Companion Animal Speciality Drugs Market growing?

Ans: The Companion Animal Speciality Drugs Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Companion Animal Speciality Drugs Market size in 2031?

Ans: The Companion Animal Speciality Drugs Market size in 2031 will be US$ 18640 million.

What is the Companion Animal Speciality Drugs Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

What is the Companion Animal Speciality Drugs Market share by application?

Ans: From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%.

Who are the main players in the Companion Animal Speciality Drugs Market report?

Ans: The main players in the Companion Animal Speciality Drugs Market are Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim, Ceva Sante Animale

What are the Application segmentation covered in the Companion Animal Speciality Drugs Market report?

Ans: The Applications covered in the Companion Animal Speciality Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Companion Animal Speciality Drugs Market report?

Ans: The Types covered in the Companion Animal Speciality Drugs Market report are Antibiotics, Anti-inflammatory Drugs, Parasiticides, Heartworm, Nutritional Products, Anti-Obesity Drugs, Skin Care Products, Vaccines

1 Companion Animal Speciality Drugs Market Overview
1.1 Product Definition
1.2 Companion Animal Speciality Drugs by Type
1.2.1 Global Companion Animal Speciality Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antibiotics
1.2.3 Anti-inflammatory Drugs
1.2.4 Parasiticides
1.2.5 Heartworm
1.2.6 Nutritional Products
1.2.7 Anti-Obesity Drugs
1.2.8 Skin Care Products
1.2.9 Vaccines
1.3 Companion Animal Speciality Drugs by Application
1.3.1 Global Companion Animal Speciality Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Companion Animal Speciality Drugs Market Size Estimates and Forecasts
1.4.1 Global Companion Animal Speciality Drugs Revenue 2020-2031
1.4.2 Global Companion Animal Speciality Drugs Sales 2020-2031
1.4.3 Global Companion Animal Speciality Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Companion Animal Speciality Drugs Market Competition by Manufacturers
2.1 Global Companion Animal Speciality Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Companion Animal Speciality Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Companion Animal Speciality Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Companion Animal Speciality Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Companion Animal Speciality Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Companion Animal Speciality Drugs, Product Type & Application
2.7 Global Key Manufacturers of Companion Animal Speciality Drugs, Date of Enter into This Industry
2.8 Global Companion Animal Speciality Drugs Market Competitive Situation and Trends
2.8.1 Global Companion Animal Speciality Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Companion Animal Speciality Drugs Players Market Share by Revenue
2.8.3 Global Companion Animal Speciality Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Companion Animal Speciality Drugs Market Scenario by Region
3.1 Global Companion Animal Speciality Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Companion Animal Speciality Drugs Sales by Region: 2020-2031
3.2.1 Global Companion Animal Speciality Drugs Sales by Region: 2020-2025
3.2.2 Global Companion Animal Speciality Drugs Sales by Region: 2026-2031
3.3 Global Companion Animal Speciality Drugs Revenue by Region: 2020-2031
3.3.1 Global Companion Animal Speciality Drugs Revenue by Region: 2020-2025
3.3.2 Global Companion Animal Speciality Drugs Revenue by Region: 2026-2031
3.4 North America Companion Animal Speciality Drugs Market Facts & Figures by Country
3.4.1 North America Companion Animal Speciality Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Companion Animal Speciality Drugs Sales by Country (2020-2031)
3.4.3 North America Companion Animal Speciality Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Companion Animal Speciality Drugs Market Facts & Figures by Country
3.5.1 Europe Companion Animal Speciality Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Companion Animal Speciality Drugs Sales by Country (2020-2031)
3.5.3 Europe Companion Animal Speciality Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Companion Animal Speciality Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Companion Animal Speciality Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Companion Animal Speciality Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Companion Animal Speciality Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Companion Animal Speciality Drugs Market Facts & Figures by Country
3.7.1 Latin America Companion Animal Speciality Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Companion Animal Speciality Drugs Sales by Country (2020-2031)
3.7.3 Latin America Companion Animal Speciality Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Companion Animal Speciality Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Companion Animal Speciality Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Companion Animal Speciality Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Companion Animal Speciality Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Companion Animal Speciality Drugs Sales by Type (2020-2031)
4.1.1 Global Companion Animal Speciality Drugs Sales by Type (2020-2025)
4.1.2 Global Companion Animal Speciality Drugs Sales by Type (2026-2031)
4.1.3 Global Companion Animal Speciality Drugs Sales Market Share by Type (2020-2031)
4.2 Global Companion Animal Speciality Drugs Revenue by Type (2020-2031)
4.2.1 Global Companion Animal Speciality Drugs Revenue by Type (2020-2025)
4.2.2 Global Companion Animal Speciality Drugs Revenue by Type (2026-2031)
4.2.3 Global Companion Animal Speciality Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Companion Animal Speciality Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Companion Animal Speciality Drugs Sales by Application (2020-2031)
5.1.1 Global Companion Animal Speciality Drugs Sales by Application (2020-2025)
5.1.2 Global Companion Animal Speciality Drugs Sales by Application (2026-2031)
5.1.3 Global Companion Animal Speciality Drugs Sales Market Share by Application (2020-2031)
5.2 Global Companion Animal Speciality Drugs Revenue by Application (2020-2031)
5.2.1 Global Companion Animal Speciality Drugs Revenue by Application (2020-2025)
5.2.2 Global Companion Animal Speciality Drugs Revenue by Application (2026-2031)
5.2.3 Global Companion Animal Speciality Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Companion Animal Speciality Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Company Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Companion Animal Speciality Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zoetis Companion Animal Speciality Drugs Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Companion Animal Speciality Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Companion Animal Speciality Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Companion Animal Speciality Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Companion Animal Speciality Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Company Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Companion Animal Speciality Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Companion Animal Speciality Drugs Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Company Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Companion Animal Speciality Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boehringer Ingelheim Companion Animal Speciality Drugs Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Ceva Sante Animale
6.6.1 Ceva Sante Animale Company Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Companion Animal Speciality Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ceva Sante Animale Companion Animal Speciality Drugs Product Portfolio
6.6.5 Ceva Sante Animale Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Companion Animal Speciality Drugs Industry Chain Analysis
7.2 Companion Animal Speciality Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Companion Animal Speciality Drugs Production Mode & Process Analysis
7.4 Companion Animal Speciality Drugs Sales and Marketing
7.4.1 Companion Animal Speciality Drugs Sales Channels
7.4.2 Companion Animal Speciality Drugs Distributors
7.5 Companion Animal Speciality Drugs Customer Analysis
8 Companion Animal Speciality Drugs Market Dynamics
8.1 Companion Animal Speciality Drugs Industry Trends
8.2 Companion Animal Speciality Drugs Market Drivers
8.3 Companion Animal Speciality Drugs Market Challenges
8.4 Companion Animal Speciality Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Companion Animal Speciality Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Companion Animal Speciality Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Companion Animal Speciality Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Companion Animal Speciality Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Companion Animal Speciality Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Companion Animal Speciality Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Companion Animal Speciality Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Companion Animal Speciality Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Companion Animal Speciality Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Companion Animal Speciality Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Companion Animal Speciality Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Companion Animal Speciality Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Companion Animal Speciality Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Speciality Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Companion Animal Speciality Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Companion Animal Speciality Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Companion Animal Speciality Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Companion Animal Speciality Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Companion Animal Speciality Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Companion Animal Speciality Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Companion Animal Speciality Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Companion Animal Speciality Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Companion Animal Speciality Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Companion Animal Speciality Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Companion Animal Speciality Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Companion Animal Speciality Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Companion Animal Speciality Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Companion Animal Speciality Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Companion Animal Speciality Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Companion Animal Speciality Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Companion Animal Speciality Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Companion Animal Speciality Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Companion Animal Speciality Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Companion Animal Speciality Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Companion Animal Speciality Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Companion Animal Speciality Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Companion Animal Speciality Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Companion Animal Speciality Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Companion Animal Speciality Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Companion Animal Speciality Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Companion Animal Speciality Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Companion Animal Speciality Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Companion Animal Speciality Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Companion Animal Speciality Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Companion Animal Speciality Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Companion Animal Speciality Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Companion Animal Speciality Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Companion Animal Speciality Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Companion Animal Speciality Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Companion Animal Speciality Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Companion Animal Speciality Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Companion Animal Speciality Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Companion Animal Speciality Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Companion Animal Speciality Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Companion Animal Speciality Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Companion Animal Speciality Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Companion Animal Speciality Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Companion Animal Speciality Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Companion Animal Speciality Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Companion Animal Speciality Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Companion Animal Speciality Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Companion Animal Speciality Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Companion Animal Speciality Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Companion Animal Speciality Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Companion Animal Speciality Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Companion Animal Speciality Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Companion Animal Speciality Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Companion Animal Speciality Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Zoetis Company Information
 Table 71. Zoetis Description and Business Overview
 Table 72. Zoetis Companion Animal Speciality Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Zoetis Companion Animal Speciality Drugs Product
 Table 74. Zoetis Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Companion Animal Speciality Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Merck Companion Animal Speciality Drugs Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Companion Animal Speciality Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Bayer Companion Animal Speciality Drugs Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. Elanco Company Information
 Table 86. Elanco Description and Business Overview
 Table 87. Elanco Companion Animal Speciality Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Elanco Companion Animal Speciality Drugs Product
 Table 89. Elanco Recent Developments/Updates
 Table 90. Boehringer Ingelheim Company Information
 Table 91. Boehringer Ingelheim Description and Business Overview
 Table 92. Boehringer Ingelheim Companion Animal Speciality Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Boehringer Ingelheim Companion Animal Speciality Drugs Product
 Table 94. Boehringer Ingelheim Recent Developments/Updates
 Table 95. Ceva Sante Animale Company Information
 Table 96. Ceva Sante Animale Description and Business Overview
 Table 97. Ceva Sante Animale Companion Animal Speciality Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Ceva Sante Animale Companion Animal Speciality Drugs Product
 Table 99. Ceva Sante Animale Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Companion Animal Speciality Drugs Distributors List
 Table 103. Companion Animal Speciality Drugs Customers List
 Table 104. Companion Animal Speciality Drugs Market Trends
 Table 105. Companion Animal Speciality Drugs Market Drivers
 Table 106. Companion Animal Speciality Drugs Market Challenges
 Table 107. Companion Animal Speciality Drugs Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Companion Animal Speciality Drugs
 Figure 2. Global Companion Animal Speciality Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Companion Animal Speciality Drugs Market Share by Type: 2024 & 2031
 Figure 4. Antibiotics Product Picture
 Figure 5. Anti-inflammatory Drugs Product Picture
 Figure 6. Parasiticides Product Picture
 Figure 7. Heartworm Product Picture
 Figure 8. Nutritional Products Product Picture
 Figure 9. Anti-Obesity Drugs Product Picture
 Figure 10. Skin Care Products Product Picture
 Figure 11. Vaccines Product Picture
 Figure 12. Global Companion Animal Speciality Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 13. Global Companion Animal Speciality Drugs Market Share by Application: 2024 & 2031
 Figure 14. Hospital
 Figure 15. Clinic
 Figure 16. Others
 Figure 17. Global Companion Animal Speciality Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Companion Animal Speciality Drugs Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Companion Animal Speciality Drugs Sales (2020-2031) & (K Pcs)
 Figure 20. Global Companion Animal Speciality Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Companion Animal Speciality Drugs Report Years Considered
 Figure 22. Companion Animal Speciality Drugs Sales Share by Manufacturers in 2024
 Figure 23. Global Companion Animal Speciality Drugs Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Companion Animal Speciality Drugs Players: Market Share by Revenue in Companion Animal Speciality Drugs in 2024
 Figure 25. Companion Animal Speciality Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Companion Animal Speciality Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Companion Animal Speciality Drugs Sales Market Share by Country (2020-2031)
 Figure 28. North America Companion Animal Speciality Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Companion Animal Speciality Drugs Sales Market Share by Country (2020-2031)
 Figure 32. Europe Companion Animal Speciality Drugs Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Companion Animal Speciality Drugs Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Companion Animal Speciality Drugs Revenue Market Share by Region (2020-2031)
 Figure 40. China Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Companion Animal Speciality Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Companion Animal Speciality Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Companion Animal Speciality Drugs Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Companion Animal Speciality Drugs Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Companion Animal Speciality Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Companion Animal Speciality Drugs by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Companion Animal Speciality Drugs by Type (2020-2031)
 Figure 62. Global Companion Animal Speciality Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Companion Animal Speciality Drugs by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Companion Animal Speciality Drugs by Application (2020-2031)
 Figure 65. Global Companion Animal Speciality Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Companion Animal Speciality Drugs Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Add to Cart

Global Prescription Dermatology Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30F12967
Thu Sep 04 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Asset Managements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28K11948
Thu Sep 04 00:00:00 UTC 2025

Add to Cart

Global Cell Therapy Technologies Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T13444
Thu Sep 04 00:00:00 UTC 2025

Add to Cart